HRR - Task - Monitoring the Cellular Immunity by in vitro Delayed Type Hypersensitivity Assay on ISS

NASA Logo Human Research Roadmap HRP Exploration Data

Evidence MDRP Risks Gaps Tasks Reports

Explore Search

- IM-101
  - Immune
- IM-105
  - Immune
- IM7
  - Immune

Monitoring the Cellular Immunity by in vitro Delayed Type Hypersensitivity Assay on ISS

Last Published: 07/30/21 01:05:34 PM (Central)

Task Book: Entry Unavailable
Principal Investigator: Chouker, Alexander

Short Title: Immunity Assay

Responsible HRP Element: Human Health Countermeasures

Collaborating Org(s):

International Partner: ESA

Funding Status: Active - Currently funded and in progress

Procurement Mechanism(s):

Directed

Aims:
To address the effects of microgravity on T-cell mitogens.

Resources (Flight)

Deliverables (1)

Category: Technology or Tool
Subcategory: Systems Solutions, Prototype Hardware or Software

Description:
This study will provide publication(s) with ESA counterparts on cellular immune data by the in vitro delayed type hypersensitivity assay on ISS. The report will contribute to gap closure by addressing the effects of microgravity on T-cell mitogens.

Internal Customers:
None External Customers:
None

Mappings

Risk of Adverse Health Event Due to Altered Immune Response

IM-101: Evaluate the effects of deep-space radiation on immune dysfunction, as an additional hazard to the effects of psychophysiological stress and weightlessness.

IM-105: Identify immune biomarkers that correlate with known spaceflight-related immune dysfunction and immune outcomes, as a first step in designing in-flight monitoring paradigms.

IM7: It is necessary to correlate the observed effects of spaceflight-associated immune system dysregulation with known terrestrial clinical conditions.

Monitoring the Cellular Immunity by in vitro Delayed Type Hypersensitivity Assay on ISS

Related Tasks (53)

Print View...

Risk Approach Plans (1)

NASA Developer: Daniel Febus Responsible NASA Official: Susan Torney Contact HRP for a 508 compliant PDF Budgets, Strategic Plans, and Accountability Reports Equal Employment Opportunity Data Posted Pursuant to the No Fear Act Information-Dissemination Policies and Inventories Freedom of Information Act President's Management Agenda Privacy Policy & Important Notices Inspector General Hotline Contact HRP Human Health and Performance DIR Johnson Space Center USA.gov ExpectMore.gov

Common Item(s)
	Risk of Adverse Health Event Due to Altered Immune Response
	IM-101: Evaluate the effects of deep-space radiation on immune dysfunction, as an additional hazard to the effects of psychophysiological stress and weightlessness.